Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Beatriz Martín-Herreros
Observed names:
B. Martín-Herreros,
Beatriz Martin-Herreros,
Beatriz Martín‐Herreros,
Martín Herreros, Beatriz
Institutions:
Hospital Universitari i Politècnic La Fe,
Hospital Universitario de Valme,
Instituto de Investigación Sanitaria La Fe
Observed institutions:
Hospital Universitari i Politècnic La Fe,
Hospital Universitario de Valme,
Instituto de Investigación Sanitaria La Fe
ORCID:
0000-0001-7286-9555
Observed ORCID:
0000-0001-7286-9555
OpenAlex ID:
A5039551042
Incidence and Risk Factors for Development of Cardiac Toxicity in Adult Patients with Newly Diagnosed Acute Myeloid Leukemia
2023
·
Blanca Boluda
, Antonio Solana-Altabella
, et al.
·
Cancers
·
19
PDF
A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients
2021
·
María P. Martínez Sánchez
, Juan Eduardo Megías-Vericat
, et al.
·
Annals of Hematology
·
17
A novel chimeric antigen receptor T-cell therapy targeting CD84 for the treatment of acute myeloid and T-cell lymphoblastic leukemias
2025
·
Lorena Pérez-Amill
, Mercedes Armand-Ugón
, et al.
·
Leukemia
·
9
PDF
Co-mutation signatures are age-dependent and impact the prognosis in NPM1-mutated acute myeloid leukemia: a PETHEMA multicenter study
2026
·
José Vicente Gil
, Claudia Sargas
, et al.
·
Haematologica
·
2
Prognostic impact of immunophenotypic classification for newly diagnosed NPM1 ‐mutated acute myeloid leukemia
2026
·
Beatriz Martín‐Herreros
, Lourdes Cordón
, et al.
·
Cytometry Part B Clinical Cytometry
·
2
PDF
Immune reconstitution after single-unit umbilical cord blood transplantation using anti-thymoglobulin and myeloablative conditioning in adults with hematological malignancies
2024
·
Lourdes Cordón
, Pedro Chorão
, et al.
·
Annals of Hematology
·
2
Prognostic impact of variant allele frequency in intensively treated patients with NPM1 -mutated AML: a PETHEMA study
2026
·
José Vicente Gil
, Claudia Sargas
, et al.
·
Blood
·
1
Cardiotoxicity in Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia
2025
·
Laura Torres-Miñana
, Blanca Boluda
, et al.
·
Cancers
·
1
PDF
Upfront venetoclax plus quizartinib with low-dose cytarabine or azacitidine in older unfit patients with acute myeloid leukemia: the phase I/II VEN-A-QUI trial
2026
·
Juan Miguel Bergua
, Pilar Lloret-Madrid
, et al.
·
Journal of Hematology & Oncology
PDF
Measurable residual disease assessment as an early end point of treatment efficacy in acute myeloid leukemia: a multinational PETHEMA study of 2623 patients treated with intensive therapy
2026
·
Bruno Paiva
, Leire Burgos
, et al.
·
Leukemia
CD84 Expression Across Disease Stages and Leukemic Subpopulations in Acute Myeloid Leukemia
2026
·
Beatriz Martín-Herreros
, Lourdes Cordón
, et al.
·
Cancers
P511: Risk Factors and Incidence of Cardiac Events in a Large Cohort of 525 Adult Patients With Newly Diagnosed Non-m3 Acute Myeloid Leukemia
2022
·
B. Boluda
, A. Solana-Altabella
, et al.
·
HemaSphere
Show more works
View as search
Works count:
13
Citation count:
54
H-index:
3
I10-index:
2
Year
Topic
Type